E-DRUG: Live map of COVID-19 evidence
----------------------------------------------
The Norwegian Institute of Public Health (fhi.no) has created a live map of
COVID Evidence. The map and information about this collaborative project
(FHI, McMaster University, Health Sciences, Cochrane Belgium, Belgian Red
Cross), can be found here:
https://www.fhi.no/en/qk/systematic-reviews-hta/map/
Text copied from the website:
We provide an overview of scientific publications on COVID-19 categorized
and parsed into more specific subgroups, providing quick access to specific
topic-relevant publications. As a result, the map also identifies research
gaps, possibly guiding further research efforts.
Our partner at McMaster University, Canada is making an evidence map of trustworthy guidelines. We conduct literature searches daily or every other day in PubMed. We will supplement the searches with material retrieved by searches performed by organizations such as WHO, CDC, and others.
We update the map weekly. As of 28 April 2020 the map contains 1,321
publications categorized by topic, population, and publication type. We have
screened 10,785 references retrieved in our searches. The map includes all
systematic reviews, RCT's, non-randomized studies with control groups and
method papers up to 23 April 2020. For all other study designs, the map is
up to date until 8 April 2020.
The main map gives an overview of all publications categorized according to
publication type, population of interest and topic. User guides can be found
in the <About>-section on the top left of each screen.
More detailed maps are available for these topics:
- Etiology
- Diagnosis
- Infection prevention and control
- Interventions to treat the infected patient
- Interventions targeted at system level
- Prognosis
- Experiences and perception, social, political, economic aspects
- Reviews on Covid-19
- Reviews made by NIPH on Covid-19
Contact details
Do you have questions or comments? Please contact us at
Covid-19.evidencemap@fhi.no
Call for collaboration
We are seeking agencies and individual contributors interested in
collaborating on this live map of COVID-19 evidence. Specifically, we are
looking for partners that want to engage in the categorization of COVID-19
studies or in the risk of bias appraisal of prioritized studies. A complete
call for collaboration is available.
----------------------------------------------------------
Kirsten Myhr, MScPharm, MPH
Kongsberg, Norway
Phone: +47 41638747
"Kirsten Myhr" <myhr@online.no>